Head of Investor Relations
MiNK Therapeutics, Inc. (INKT)Equibles does not estimate personal net worth.
Get an email with a short summary when MiNK Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get INKT alertsZack Armen is recorded as Head of Investor Relations at MiNK Therapeutics, Inc. (INKT). Zack Armen has spoken on 8 earnings calls across 1 company, most recently for MiNK Therapeutics, Inc. on August 14, 2025. MiNK Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at MiNK Therapeutics, Inc. includes Melissa Orilall (CFO), Austin Charette (Chief Accounting Officer), Dr. John Holcomb (Board Member) and 5 others.
“Today's call is being webcast and will be available on our website for replay. I'd like to remind you that this call will include forward-looking statements, including those related to our clinical development, regulatory and commercial plans, timelines for data release, and partnership opportunities.”
“Today's call is being webcast and will be available on our website for replay. I'd like to remind you that this call will include forward-looking statements, including those related to our clinical development, regulatory and commercial plans, timelines for data release, and partnership opportunities.”
“Today’s call is being webcast and will be available on our website for replay. I’d like to remind you that this call will include forward-looking statements, including those related to our clinical development, regulatory and commercial plan, timelines for data release and partnership opportunities.”
“Today's call is being webcast and will be available on our website for replay. I'd like to remind you that our discussion includes statements regarding our clinical development, regulatory and commercial plans and timelines, as well as timelines for data release and partnership opportunities, among other updates.”
“Today's call is being webcast and will be available on our website for replay.”
Biotechnology · Healthcare
Head of Investor Relations
